[HTML][HTML] A systematic review of pharmacologic treatment efficacy for depression in older patients with cancer

EE Rabin, M Kim, A Mozny, K Cardoza, AC Bell… - Brain, Behavior, & …, 2022 - Elsevier
Background Older adults≥ 65 years of age represent the majority of new cancer diagnoses
and are vulnerable to developing depression-like symptoms. Evaluation and management …

A systematic review of pharmacologic treatment efficacy for depression in older patients with cancer

EE Rabin, M Kim, A Mozny… - Brain, behavior, & …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Older adults≥ 65 years of age represent the majority of new cancer diagnoses
and are vulnerable to developing depression-like symptoms. Evaluation and management …

A systematic review of pharmacologic treatment efficacy for depression in older patients with cancer.

EE Rabin, M Kim, A Mozny, K Cardoza… - Brain, Behavior, & …, 2022 - europepmc.org
Background Older adults≥ 65 years of age represent the majority of new cancer diagnoses
and are vulnerable to developing depression-like symptoms. Evaluation and management …

[HTML][HTML] A systematic review of pharmacologic treatment efficacy for depression in older patients with cancer

EE Rabin, M Kim, A Mozny, K Cardoza… - Brain, Behavior, & …, 2022 - ncbi.nlm.nih.gov
Background Older adults≥ 65 years of age represent the majority of new cancer diagnoses
and are vulnerable to developing depression-like symptoms. Evaluation and management …

A systematic review of pharmacologic treatment efficacy for depression in older patients with cancer

EE Rabin, M Kim, A Mozny… - Brain, Behavior …, 2022 - scholars.northwestern.edu
Background: Older adults≥ 65 years of age represent the majority of new cancer diagnoses
and are vulnerable to developing depression-like symptoms. Evaluation and management …

A systematic review of pharmacologic treatment efficacy for depression in older patients with cancer.

EE Rabin, M Kim, A Mozny, K Cardoza… - Brain, Behavior, & …, 2022 - europepmc.org
Background Older adults≥ 65 years of age represent the majority of new cancer diagnoses
and are vulnerable to developing depression-like symptoms. Evaluation and management …